Sumitomo Pharma (Growject) Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Sumitomo Pharma (Growject) General Information

Description

Manufacturer of growth hormone preparations intended to treat growth hormone deficiency and related conditions. The company offers genetically modified natural human growth hormone preparations, providing healthcare providers with treatments for growth hormone deficiency.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Osaka
  • Japan
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
JCR Pharmaceuticals
Vertical(s)
Manufacturing
Corporate Office
  • Osaka
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sumitomo Pharma (Growject) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sumitomo Pharma (Growject)‘s full profile, request access.

Request a free trial

Sumitomo Pharma (Growject) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sumitomo Pharma (Growject)‘s full profile, request access.

Request a free trial

Sumitomo Pharma (Growject) FAQs

  • When was Sumitomo Pharma (Growject) founded?

    Sumitomo Pharma (Growject) was founded in 1995.

  • Where is Sumitomo Pharma (Growject) headquartered?

    Sumitomo Pharma (Growject) is headquartered in Osaka, Japan.

  • What industry is Sumitomo Pharma (Growject) in?

    Sumitomo Pharma (Growject)’s primary industry is Pharmaceuticals.

  • Is Sumitomo Pharma (Growject) a private or public company?

    Sumitomo Pharma (Growject) is a Private company.

  • What is Sumitomo Pharma (Growject)’s current revenue?

    The current revenue for Sumitomo Pharma (Growject) is .

  • Who are Sumitomo Pharma (Growject)’s investors?

    Sumitomo Pharma has invested in Sumitomo Pharma (Growject).

  • When was Sumitomo Pharma (Growject) acquired?

    Sumitomo Pharma (Growject) was acquired on 01-Jul-2010.

  • Who acquired Sumitomo Pharma (Growject)?

    Sumitomo Pharma (Growject) was acquired by JCR Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process